Log In
BCIQ
Print this Print this
 

THA902

  Manage Alerts
Collapse Summary General Information
Company Theralpha S.A.S.
DescriptionLong-acting formulation ASIC3 inhibitor using Medusa technology
Molecular Target Acid-sensing ion channel-3 (ASIC3) (ACCN3)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
PartnerFlamel Technologies S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/16/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today